Chicago, Ill, and Indianapolis, Ind Background: Mechanisms for the development of food allergy in neonates are unknown but clearly linked in patient populations to a genetic predisposition to skin barrier defects. Whether skin barrier defects contribute functionally to development of food allergy is unknown. Objective: The purpose of the study was to determine whether skin barrier mutations, which are primarily heterozygous in patient populations, contribute to the development of food allergy. Methods: Mice heterozygous for the filaggrin (Flg) ft and Tmem79 ma mutations were skin sensitized with environmental and food allergens. After sensitization, mice received oral challenge with food allergen, and then inflammation, inflammatory mediators, and anaphylaxis were measured. Results: We define development of inflammation, inflammatory mediators, and food allergen-induced anaphylaxis in neonatal mice with skin barrier mutations after brief concurrent cutaneous exposure to food and environmental allergens. Moreover, neonates of allergic mothers have increased responses to suboptimal sensitization with food allergens. Importantly, responses to food allergens by these neonatal mice were dependent on genetic defects in skin barrier function and on exposure to environmental allergens. ST2 blockade during skin sensitization inhibited the development of anaphylaxis, antigen-specific IgE, and inflammatory mediators. Neonatal anaphylactic responses and antigen-specific IgE were also inhibited by oral pre-exposure to food allergen, but interestingly, this was blunted by concurrent pre-exposure of the skin to environmental allergen. Conclusion: These studies uncover mechanisms for food allergy sensitization and anaphylaxis in neonatal mice that are
Acute allergic responses range from mild itching in the mouth, hives, and abdominal discomfort to severe life-threatening anaphylaxis. There is no cure. Therapy includes strict avoidance of the food allergens and management of reactions with use of epinephrine for accidental consumption, although recent efforts in tolerance induction have shown some promise. Reports of food allergy prevalence indicate 6% of young children have food allergies, with an up to 18% increase in prevalence from 1997 and 2007. [1] [2] [3] Food allergies often develop early in life. Offspring of allergic mothers or fathers have increased incidence of food allergies. 4 The risk for allergic disease in human subjects is associated with in utero and early exposures to environmental factors. 5 In animal studies we and others have reported that offspring from allergic mothers are predisposed to allergic lung responses to suboptimal allergen doses. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] It is not known whether offspring of allergic mother mice have increased responsiveness to sensitization to food allergens and food-induced anaphylaxis.
In adult mouse models of food allergy, tolerance to food antigens is broken by oral administration of food antigens with cholera toxin [16] [17] [18] [19] or staphylococcal enterotoxin B (SEB). 20 However, cholera is not prevalent in patients with food allergies. Moreover, cholera outbreaks have not occurred in countries with prevalent food allergies. [21] [22] [23] [24] [25] For SEB, induction of food allergy by oral coadministration of food antigen and SEB is reported by some, 20 but not others, 26 to break tolerance to food antigens in wild-type (WT) mice. The cholera toxin and SEB models have been used to examine approaches for inhibition of established food allergy. However, mechanisms for the development of food allergy from environmental exposure are not known.
Early in life, food allergy is often associated with atopic dermatitis. Atopic dermatitis results in skin barrier dysfunction and itchy, red, swollen, and cracked skin. Early onset of atopic dermatitis is associated with increased risk of allergic sensitization to food allergens by age 2 years and asthma by age 7 years. 27, 28 Moreover, IgE-mediated food allergy is observed in up to 35% in children affected with atopic dermatitis. 29 This suggests that interventions early in life might influence the association of atopic dermatitis with food allergies. Atopic dermatitis in human subjects is associated with mutations in the skin barrier genes SPINK5, a serine peptidase inhibitor; CDSN, a structural protein of corneodesmosomes in the stratum corneum; filaggrin (FLG), a filament-associated protein that cross-links keratin fibers in keratinocytes 31 ; and mattrin, a transmembrane protein involved in stratum corneum barrier function. 32 Whether atopic patients without these skin barrier mutations have other unidentified mutations is not known. FLG expression in keratinocytes can also be decreased during inflammation with IL-4 and IL-13 expression. 33 Several Flg mutations are risk factors for allergy development, 34, 35 including peanut allergy. 36, 37 The Flg and mattrin genes affect skin barrier function. Mutations in both of these genes predispose human subjects and mice to atopic dermatitis. 32 Flaky tail mice, with mutations in Flg (Flg ft ) and mattrin (Tmem79 ma ), 32 are used in studies of the generation of localized sites of atopic dermatitis, skin allergic responses, and lung asthmatic responses. 34, [38] [39] [40] A report indicates that transcriptomes for inflammation vary between unchallenged flaky tail mice and patients with atopic dermatitis, but it is important to appreciate the differences in skin exposures and thus stimulation for human subjects versus mice in barrier facilities. 41 Although it is speculated that decreased barrier function increases allergen exposure, it is not known how skin barrier mutations affect sensitization to food allergens.
Atopic dermatitis and allergies are associated with fungal and house dust mite (HDM) exposure. 42 HDMs, the fungal allergen Alternaria alternata, and food antigens, such as peanuts, are present in house dust. [43] [44] [45] [46] [47] HDM is a ubiquitous indoor allergen, and the fungal allergen A alternata is a ubiquitous indoor and outdoor allergen to which neonates are exposed. Healthy skin and skin of patients with atopic dermatitis show the fungi Alternaria and Malassezia species. 48 Fungal extracts exhibit broad cross-reactivity among fungi. 42 Compared with healthy subjects, patients with atopic dermatitis show a higher frequency of IgE reactivity to the skin yeast Malassezia species [49] [50] [51] and the allergen HDM. 51 Patients with atopic dermatitis can also have Alternaria species-reactive IgE. 52 The mechanisms for these associations with atopic dermatitis are unclear but can be attributed to a combination of a dysfunctional skin barrier, genetics, and environmental exposures early in life. 49 In human subjects expression of skin barrier mutations is predominantly heterozygous. 53 Thus we used FT mice as a representative of skin barrier defects. Heterozygous FT 1/2 mice were used, where 2 indicates the presence of the mutation. In our studies, neonatal FT 1/2 mice had allergic skin responses with increased T H 2 cytokine, chemokine, and antigen-specific IgE levels after skin sensitization with peanut or chicken egg ovalbumin and coexposure to A alternata or HDM. These sensitized neonates had anaphylaxis in response to oral gavage with the food antigen. The responses required heterozygous expression of skin barrier mutations and required costimulation with A alternata or HDM extract. ST2 blockade during skin sensitization inhibited anaphylaxis and inflammatory mediators. Interestingly, the FT 1/2 offspring of allergic WT mothers had increased responses to suboptimal skin challenges compared with FT 1/2 offspring of nonallergic WT mothers. In addition, skin pre-exposure to A alternata reduced tolerance induced by oral pre-exposure to food allergen. These mechanistic studies reflect early-life allergen exposures and genetic mutations that are consistent with the clinical manifestations of the development of food allergies. were housed under specific pathogen-free barrier conditions. Flaky tail mice on the C57BL/6 background have been described previously. 32, 34, [38] [39] [40] Mouse bedding was ¼-inch Coarse Aspen Sani Chips (catalog no. 7115; Harlan Laboratories, Indianapolis, Ind), and the diet was Teklad Irradiated LM-485 mouse diet (catalog no. 7912; Envigo, Madison, Wis). All mice were selected randomly for the studies. The studies are approved by the Northwestern University Institutional Review Committee for animals.
METHODS Mice

Allergens
A alternata extract (catalog no. XPM1D3A2.5) and HDM extract (Dermatophagoides pteronyssinus extract, catalog no. XPB82D3A2.5) were from Greer Laboratories (Lenoir, NC). These are standard extracts from Greer used for patient immunotherapy. Chicken egg ovalbumin fraction V (OVA; catalog no. 9006-59-1) was from Sigma (St Louis, Mo). To generate peanut extract (PNE), peanuts (Planters Lightly Salted Dry Roasted Peanuts) were ground, and then 25 g were homogenized in 250 mL of 20 mmol/L Tris-buffered saline (TBS), pH 7.2. 54 This solution was stirred for 2 hours at room temperature and centrifuged at 3000g for 30 minutes. The aqueous middle layer was collected and centrifuged at 1600g for 45 minutes to remove residual particles and fat. The aqueous layer was collected. Protein concentrations were determined by using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, Mass). Aliquots were stored at 2208C. SDS-PAGE after coincubation of the allergens in vitro was performed, as described in the Methods section in this article's Online Repository at www.jacionline.org.
Allergen sensitization
Generation of allergic mothers. Female mice at 4 to 6 weeks of age were sensitized by means of intraperitoneal injection (200 mL) of OVA grade V (5 mg)/alum (1 mg) or saline/alum (1 mg) on days 0 and 7 [6] [7] [8] 14, 15 and then received nebulized saline or 3% (wt/vol) OVA in saline for 20 minutes 3 times a week on weeks 4, 8, 12, and 16 weeks. At the last challenge in week 16, allergic or nonallergic female mice were mated with 3-to 4-month-old WT or homozygous flaky tail (FT 2/2 ) nonallergic male mice.
Treatment of offspring. FT
1/2 offspring produced from the mating of WT C57BL/6 female mice with FT 2/2 male mice were confirmed by means of genotyping (see the Methods section in this article's Online Repository). At 3 days old, pups were gently taped 5 times on the back with 3M surgical hypoallergenic paper tape (3M, Maplewood, Minn) and wiped once with 4% SDS in sterile deionized water 55 on a sterile gauze. After 3 minutes, A alternata extract or HDM extract (10 mg of protein in 5 mL of sterile saline) was applied to the pup skin, and then PNE or OVA (100 mg of protein in 10 mL of sterile saline) was applied to the same area on the back. The pups were placed in a cage without the mother for 40 minutes. 56 Then the pups were washed gently with water on a paper towel and wiped dry to remove free antigen from the surface 56 before placing the pups back with the mother to prevent antigen consumption during grooming by the mother. The antigen applications were repeated 1 to 2 times per week, as indicated in the figures, but on pups that are older than 5 days, the fur was shaved before tape stripping. The taping did not overtly disrupt the skin but gently removed dried skin after birth or hair after shaving (see Fig E1 in Tolerance induction. In studies with oral tolerance, pups received 100 mL of 10 mg/mL PNE by means of gavage on 4 days before skin sensitization.
ST2 blockade. The pups treated with anti-ST2 (catalog no.
MAB10041; R&D Systems, Minneapolis, Minn) or isotype control (catalog no. 400544; BioLegend, San Diego, Calif) received an intraperitoneal injection of 8 mg of antibody in saline per gram of pup weight at 1 hour before skin sensitization number 1, 12 mg of antibody/g of pup weight at 1 hour before skin sensitization numbers 2 and 3, and then 15 mg of antibody/g of pup weight at 1 hour before skin sensitization number 4.
Oral antigen challenge, anaphylaxis, and tissue analysis
At 48 hours after the last allergen skin sensitization indicated in the figure timelines, baseline rectal temperatures of the pups were taken with a BAT-12 Microprobe Thermometer with a RET-4 thermocouple sensor type T rectal probe for neonatal mice (Physitemp Instruments, Clifton, NJ). Then the pups received PNE or OVA by means of gavage (100 mL of 10 mg of protein/mL of sterile saline) with a 24-gauge gavage needle (Pet Surgical, Agoura Hills, Calif). Rectal temperatures were taken every 15 to 20 minutes for up to 105 minutes. The pups were placed back with the mothers until they were killed, and tissues were collected. Tissue sections were stained for eosinophils and mast cells or examined by using quantitative RT-PCR (qRT-PCR) for inflammatory mediators (see the Methods in this article's Online Repository). Eosinophils and mast cells in tissue sections were counted by using light microscopy in 10 high-powered fields in a blind fashion. Levels of serum antipeanut antibodies (IgE, IgG 2b , IgG 1 , and IgA), serum anti-OVA antibodies, and mast cell protease 1 (Mcpt-1) were determined by means of ELISA (see the Methods section in this article's Online Repository). Endotoxin was measured with a chromogenic quantitation kit (see the Methods section in this article's Online Repository).
Statistics
Data were analyzed by using 1-way ANOVA followed by the Tukey multiple comparisons test or t test (SigmaStat; Jandel Scientific, San Ramon, Calif). Presented are means 6 SE. Statistical analysis for the change in temperature was done by using the maximum change in temperature. Data in the figures include both sexes for the offspring because there were no differences in outcomes by sex (see Fig E2 in 
RESULTS
Skin sensitization of neonates with skin barrier gene mutations induced responsiveness to oral food allergen-induced anaphylaxis Because human subjects are predominantly heterozygous for skin barrier mutations, skin of neonatal mice with heterozygous mutations was exposed to environmental and food allergens. FT mice were used as a model representative of skin barrier mutations. Briefly, female WT mice were bred with male FT 2/2 mice that are homozygous for the Flg flaky tail (ft) mutation and Tmem79 ma mutation, yielding heterozygous FT 1/2 pups for both the Flg ft and Tmem79 ma mutations (Fig 1, A) . Pups were sensitized on postnatal day (PND) 3 and then every 2 to 3 days (Fig 1, A) . To remove dry shedding skin after birth or fur after shaving, the pup skin underwent 5 gentle tape applications with 3M Micropore paper hypoallergenic surgical paper tape, a . Data in all figures include both sexes for pups because there were no differences in outcomes by sex (see Fig E2) . *P < .05 compared with the saline skin-sensitized group and the PNE-only skin-sensitized group. Alt, Alternaria alternata extract; FT1/2, flaky tail mice heterozygous for filaggrin and for mattrin mutations; FT2/2, flaky tail mice homozygous for filaggrin and mattrin mutations.
nonirritating general purpose paper tape that is gentle on the skin, resulting in very little trauma to the neonate skin (see Fig E1) ; this is in contrast to the skin trauma induced by more adhesive tapes, such as 3M Tegaderm adhesive film. 57 For applications after PND9, the pups were shaved to remove fur, which can induce small nicks (see Fig E1) analogous to infant scratching with atopic dermatitis. This skin site was then wiped once with 4% SDS in water, which resembles use of a cleansing wipe on infants. Then the pups received cutaneous application of A alternata extract, HDM extract, A alternata extract with HDM, or saline (Fig 1, A and B, and see Fig E3, A and B in this article's Online Repository at www.jacionline.org). Immediately afterward, the food allergen PNE (Fig 1, B) or OVA (see Fig E2, B) was applied to the skin. Two days after the last skin application, the pups received oral gavage with 100 mg of PNE (Fig 1, B) or OVA (see Fig E2, B) , and rectal temperature was monitored. All offspring were FT 1/2 mice, as determined by means of genotyping (data not shown). Anaphylaxis occurred only in the pups that received skin application of HDM or A alternata extract with the food allergen PNE (Fig 1, B) or OVA (see Fig E2, B) . Pups with PNE only or saline on the skin did not have anaphylaxis with oral challenge, and therefore for subsequent experiments, the PNE-only skin-treated groups served as the negative control group. For pups in Fig 1, B, there were no differences in anaphylaxis by sex (see Fig E3, A) and no differences for sex or treatment groups in initial body temperature immediately before oral challenge (see Fig E3, B) . Thus A alternata extract or HDM was required for skin sensitization with PNE or OVA in the FT 1/2 pups. Serum contained anti-PNE-specific IgE and IgG 2b but not serum anti-PNE-specific IgG 1 or monomeric IgA in pups with coapplication of HDM or A alternata extract with PNE (Fig 1, C) . There were no anti-PNE-specific antibodies in pups with PNE-only skin sensitization (Fig 1, C) . Serum of OVA-sensitized pups contained anti-OVA-specific IgE with coapplication of HDM or A alternata extract with OVA, but not OVA alone (see Fig E2, C) .
Pup skin was not exposed to appreciable amounts of endotoxin in PNE, A alternata extract, HDM, or OVA, but there was considerable endotoxin in fecal pellets in the mouse cage (see Fig E5 in this article's Online Repository at www.jacionline.org).
To determine whether A alternata extract or HDM, which might contain proteases, altered the molecular weights of the major proteins in the PNE, A alternata extract or HDM was incubated with PNE (see Fig E4 in this article's Online Repository at www.jacionline.org). The amounts of A alternata extract, HDM, PNE, A alternata extract/PNE, or HDM/PNE that had been applied to the pup skin for 40 minutes (Fig 1, B) were placed in a tube for 20 or 40 minutes at room temperature and then examined by using SDS-PAGE and staining with SimplyBlue protein dye (see Fig E4) . There was no change in the size of the major protein bands (see Fig E4) .
Skin barrier gene mutations were required for oral food allergen-induced anaphylaxis and generation of anti-peanut-specific IgE in FT 1/2 offspring of allergic and nonallergic mothers
To determine whether mutations in the FT 1/2 pups were required for skin sensitization to food allergens, nonallergic WT female mice or OVA-allergic WT female mice ( offspring of allergic and nonallergic mothers. A, Timeline for mating of female mice with FT 2/2 male or WT male mice and for pup treatments with food and environmental allergens. i.p., Intraperitoneal. B, Food allergeninduced temperature changes on day 21. C, Anti-peanut-specific antibodies were measured by using ELISA. Serum was from pups in Fig 2, B. Anti-peanut-specific serum IgE levels were measured with a 1:10 serum dilution and a 12-minute TMB color development. Anti-peanut-specific serum IgG 2b levels were measured with a 1:1000 serum dilution and a 12-minute TMB color development. Anti-peanut-specific serum IgG 1 levels were measured with a 1:20,000 serum dilution and a 6-minute TMB color development. Anti-peanut-specific monomeric serum IgA levels were measured by using a 1:10 serum dilution and a 30-minute TMB substrate color development (n 5 8-10 per group). *P < .05 compared with the corresponding PNEonly skin-sensitized groups compared with group 1 for FT 1/2 pups of saline-treated mothers and compared with group 4 for FT 1/2 pups of allergic mothers. For WT pups, there was no difference compared with group 8. Alt, Alternaria alternata extract; FT1/2, flaky tail mice heterozygous for filaggrin and for mattrin mutations; FT2/2, flaky tail mice homozygous for filaggrin and mattrin mutations.
FT 1/2 pups of nonallergic mothers occurred in the A alternata extract/PNE-sensitized pups (Fig 2, B, group 2) but not in the pups sensitized with PNE alone and not in the A alternata extract/PNE-sensitized WT pups (Fig 2, B, groups 1 and 3 ). For pups of allergic mothers, anaphylactic responses occurred in the A alternata extract/PNE-sensitized or HDM/PNE heterozygous FT 1/2 pups (Fig 2, B , groups 5 and 6) but not in the pups sensitized with PNE alone (Fig 2, B, group 1) and not in WT pups with skin treatments with saline, PNE, A alternata extract/PNE, or HDM/PNE (Fig 2, B, groups 4 and 7-10 ). The group 2 pups of nonallergic mothers and group 5 pups of allergic mothers are not significantly different. These data demonstrate that skin barrier mutations were required for development of food allergen responses.
Serum anti-PNE-specific IgE was generated in FT 1/2 pups of nonallergic and allergic mothers sensitized with A alternata extract/PNE but not in pups sensitized with PNE alone or in the A alternata extract/PNE-treated WT pups (Fig 2, C) . Interestingly, the FT 1/2 pups of allergic mothers also had increased relative levels of serum anti-peanut IgG 2b (Fig 2, C) . There were increased relative levels of serum anti-PNE-specific monomeric IgA in pups of allergic mothers (Fig 2, C , groups 5 and 6) but not pups of nonallergic mothers (Figs 1, C, and 2, C, group 2). The role of serum monomeric IgA in allergy is incompletely understood. 58 Allergic mothers transmitted to FT 1/2 pups an increased responsiveness to oral food allergen anaphylaxis after suboptimal pup skin sensitization Food allergy in pups of allergic mothers was examined because pups of allergic mothers have increased allergic lung responses to a suboptimal number of sensitizations with allergen, even if the allergen of the pup differs from the allergen of the mother. 7, 8, 14, 15, 59, 60 This is also evident in human subjects, in whom a family history of allergic disease is one of the strongest risk factors for development of atopic disease in children. 4, [61] [62] [63] [64] [65] It is not known whether offspring of allergic mothers respond to suboptimal food allergen sensitization. We determined whether 3 to 6 skin sensitizations were suboptimal in FT 1/2 pups of nonallergic mothers but sufficient for anaphylaxis in FT 1/2 pups of allergic mothers (Fig 3, A) . The oral challenge was designed to be at least 13 days after the first skin sensitization to ensure time for activation of acquired immune responses, including T-cell responses and plasma cell generation. After 3 skin sensitizations, anaphylaxis did not occur in pups of nonallergic mothers, but anaphylaxis did occur in pups of allergic mothers (Fig 3, B, upper panel). At 4, 5, or 6 skin sensitizations, the pups of allergic and nonallergic mothers generated anaphylactic responses (Fig 3, B, upper panel) . The younger pups had lower basal body temperatures (see Fig E7 in this article's Online Repository at www.jacionline.org). The temperature decreases were greatest in younger pups (Fig 3, B) , which is consistent with the reduced ability of newborns and young infants to control temperature. [66] [67] [68] [69] The FT 1/2 pups sensitized 3 to 6 times with only PNE did not exhibit anaphylaxis to PNE (Fig 3, B, lower panel) . Serum antipeanut IgE was present in FT 1/2 pups of allergic mothers after 3 skin sensitizations (Fig 3, C, middle panel) , whereas serum anti-peanut IgE was only detected after 4 skin sensitizations in pups of nonallergic mothers (Fig 3, C, right panel) . Furthermore, A alternata extract/PNE skin-treated pups had increased Mcpt-1 levels in the serum compared with those in PNE skin-treated pups (Fig 3, D) .
Cells and mediators of allergic responses were examined in the pups from Fig 3. In the pups with 6 A alternata extract/ PNE skin sensitizations, there was an increase in total numbers of skin mast cells in pups of allergic mothers but not pups of nonallergic mothers (Fig 4, A and B) . Although there was no increase in mast cell numbers in pups of nonallergic mothers (Fig 4, A and B) , these mast cells degranulated (Fig 4, C) , and the pups underwent anaphylaxis (Fig 3, B) . The number of degranulated skin mast cells, a measure of mast cell activation, was increased in A alternata extract/PNE-sensitized pups of allergic and nonallergic mothers compared with pups with PNE-only treated skin (Fig 4, C) . There were more degranulated skin mast cells in A alternata extract/PNE-sensitized pups of allergic mothers compared with A alternata extract/ PNE-sensitized pups of nonallergic mothers (Fig 4, C) . Numbers of skin and blood eosinophils were also increased in pups sensitized with A alternata extract/PNE compared with pups with PNE-only treated skin (Fig 4, D-F ). Skin and blood of A alternata extract/PNE-sensitized pups of allergic mothers had significantly more eosinophils than those of nonallergic mothers (Fig 4, D-F) .
Because allergic inflammation is initiated in epithelial tissues through production of cytokines and chemokines, it was determined whether skin sensitization induced skin expression of CCL11, thymic stromal lymphopoietin (TSLP), and IL-33. CCL11, TSLP, and IL-33 levels were increased in skin of pups with skin applications of A alternata extract/PNE compared with pups with PNE-only treated skin (Fig 4, G) . Moreover, at 3 skin applications of A alternata extract/PNE, the skin of pups from allergic mothers had higher amounts of CCL11 and TSLP than the skin of pups from nonallergic mothers (Fig 4, G) . At 6 skin applications, there was no difference in CCL11 and TSLP expression for A alternata extract/PNE-treated pups of allergic and nonallergic mothers, suggesting that maximal induction might have occurred. In pups with 6 skin applications, TSLP levels were also increased in the jejunum at 6 hours after only a single oral gavage with PNE (Fig 4, G) . Numbers of eosinophils and degranulated mast cells were increased similarly in the intestines of the A alternata extract/PNE-sensitized pups of allergic and nonallergic mothers compared with those in pups with PNEonly treated skin (Fig 5) .
Anti-ST2 administration at the time of skin sensitization blocked oral antigen-induced anaphylaxis IL-33 has a key role in initiation of allergic responses in the skin and lung, 70, 71 regulates mast cells, 72, 73 and reduces anaphylaxis in a food model with 49 days of sensitization. 74 In Figs 3 to 6, IL-33 levels were increased, and mast cells were degranulated in the skin and intestine. Therefore we determined whether blocking the IL-33 receptor ST2 blocks anaphylaxis. FT 1/2 pups were treated with blocking anti-ST2 antibodies or IgG 2b isotype control antibodies 1 hour before each skin sensitization, as in Fig 6, A and B. Anti-ST2, but not the isotype control antibody, blocked oral PNE-induced anaphylaxis (Fig 6, B) ; blocked the increase in anti-PNE-specific IgE, IgG 2b , and IgG 1 (Fig 6, C) ; and blocked the increase in serum Mcpt-1 levels (Fig 6, D) .
Oral pre-exposure to PNE induced tolerance, but this was less effective when FT 1/2 pup skin was exposed to the ubiquitous environmental allergen A alternata Recent clinical data from the Learning Early about Allergy to Peanut study suggests that early-life oral introduction of peanut reduces the frequency of peanut allergy. 75, 76 Whether early introduction of oral peanut prevents food allergen sensitization through cutaneous skin exposure is not known. We determined whether daily oral gavage on PND3 to PND6 with PNE in TBS reduces FT 1/2 pup skin sensitization compared with administration of the solvent control TBS (Fig 7, A) . After oral ) male or WT male mice, and pup treatments with food and environmental allergens. i.p., Intraperitoneal. B, Food allergen-induced temperature changes after oral gavage on days 13, 15, 19, or 22. C, Serum was from pups in Fig 3, B. In the panel on the left, anti-peanut-specific serum IgE levels were measured by using a 1:10 serum dilution and a 12-minute TMB substrate color development. In the 2 panels on the right, anti-peanut-specific serum IgE levels were measured with a 1:2 serum dilution and a 20-to 30-minute TMB color development. D, Serum Mcpt-1 levels were measured by using ELISA (n 5 8-10 per group). *P < .05 compared with the corresponding PNE-only skintreated group; **P < .05 compared with the indicated groups of A alternata extract/PNE-treated pups from nonallergic saline-treated mothers. Alt, Alternaria alternata extract; FT1/2, flaky tail mice heterozygous for filaggrin and for mattrin mutations; FT2/2, flaky tail mice homozygous for filaggrin and mattrin mutations. The yellow arrow indicates a degranulated mast cell. B, Pups had 6 skin sensitizations (6x ss), and skin was collected on PND22. Presented is the number of skin mast cells in 10 high-powered fields at 340 magnification (HPF) per pup tissue section from 8 to 10 pups. C, Pups had 6 skin sensitizations (6x ss), and skin was collected on PND22. Presented is the number of degranulated skin mast cells in 10 high-powered fields at 340 magnification (HPF) per pup tissue section from 8 to 10 pups. D, Shown are micrographs of eosinstained skin tissue section with a light hematoxylin counterstain from pups with 6 skin sensitizations and skin collected on PND22. Black arrows indicate eosinophils. E, Number of eosinophils in 10 highpowered fields at 340 magnification (HPF) from pups with 6 skin sensitizations (6x ss) and skin collected on PND22. F, Number of blood eosinophils, as determined by using Discomb staining and hemacytometer counting, from pups with 6 skin sensitizations and blood collected on PND22. G, RT-qPCR of pup skin TSLP and CCL11 expression for pup skin after 3 skin sensitization (3x ss) with skin collected on PND12 or 6 skin sensitizations (6xss) with skin collected on PND22. RT-qPCR of IL-33 after 4 skin sensitizations (4x ss) with skin collected in PND16. RT-qPCR of TSLP for jejunum from pups with 6 skin sensitizations (6x ss) and intestine collection on PND22 (n 5 8-10 per group). *P < .05 compared with the corresponding PNE-only skin-treated group; **P < .05 compared with the A alternata extract/PNE-treated pups from nonallergic saline-treated mothers and compared with corresponding PNE skin-treated group from allergic mothers. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase.
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 5 administration, all pups received 5 skin applications of A alternata extract/PNE on PND6, PND8, PND10, PND14, and PND18 (Fig 7, A) . Pre-exposure to PNE by means of oral gavage blocked the development of anaphylaxis in FT 1/2 pups of nonallergic mothers (Fig 7, B) and allergic mothers (Fig 8, B) . WT pups did not have anaphylaxis (Fig 7, B) . Remarkably, for FT 1/2 pups of allergic or nonallergic mothers (Fig 8, B) , skin exposures to A alternata extract concurrent with each oral pre-exposure to PNE reduced the protective effect and resulted in anaphylaxis (Fig 8, B , groups 4 and 7, and see Fig E8 in this article's Online Repository at www.jacionline.org).
Mediators of initiation of allergic responses were assessed at 6 hours after the PND20 oral PNE gavage for pups in Fig 7, B. A alternata extract/PNE-sensitized FT 1/2 pup intestines had increased TSLP and IL-33 levels (Fig 7, C-E, group 3) . This increase in TSLP levels was blocked by oral PNE pre-exposures on PND3, PND4, PND5, and PND6 (Fig 7, C-E, group 4) . Pups with 4 pre-exposures to A alternata extract only before skin sensitization had a significant increase in antibodies (Fig 8, C, group 3 ) compared with those with skin sensitization without the A alternata extract pre-exposures (Fig 8, C, group 1 or 5) . Interestingly, the A alternata extract/PNE-induced anti-PNE-specific IgE and IgG 2b antibodies (Fig 7, F, group 3) were blocked by pre-exposure with oral PNE (Fig 7, F, group 4) . However, the Oral pre-exposure to PNE induced tolerance in FT 1/2 pups. A, Timeline for induction of mating of female mice with FT 2/2 male or WT male mice, for pup pre-exposures on PND3 to PND6, and for pup skin treatments on PND6 to PND18 with food and environmental allergens. Intestines were flushed with saline before RT-qPCR analysis. B, Food allergen-induced temperature changes after oral gavage on days 20. *P < .05 compared with all other groups. C-E, For pups from Fig 7, B, we show RT-qPCR of pup skin TSLP (Fig 7, C) , pup intestinal TSLP (Fig 7, D) , and pup ileal IL-33 (Fig 7, E) . F, Anti-peanut-specific serum IgE, IgG 2b , IgG 1 , and IgA levels from pups in panel 2, as determined by means of ELISA. *P < .05 compared with groups 1, 2, and 4. Alt, Alternaria alternata extract; FT1/2, flaky tail mice heterozygous for filaggrin and for mattrin mutations; FT2/2, flaky tail mice homozygous for filaggrin and mattrin mutations.
FIG 8.
Oral pre-exposure to PNE to induce tolerance in FT 1/2 pups was less effective when their skin was preexposed to the ubiquitous environmental allergen A alternata during oral pre-exposure to PNE. A, Timeline for induction of OVA-induced lung inflammation in female mice, mating of female mice with FT 2/2 male mice, and pup pre-exposures on PND3 to PND6, pup skin sensitization on PND6 to PND18 with food and environmental allergens, and oral challenge on PND20. i.p., Intraperitoneal. B, Food allergen-induced temperature changes after oral gavage on day 20. *P < .05 compared with the group without the asterisk. C, Anti-peanut-specific serum IgE, IgG 2b , IgG 1 , and monomeric IgA levels from pups in Fig 8, B , as determined by means of ELISA. *P < .05 compared with all groups without 1 asterisk; **P < .05 compared with the indicated group. N 5 8 to 10 pups per group. Alt, Alternaria alternata extract; FT1/2, flaky tail mice heterozygous for filaggrin and for mattrin mutations; FT2/2, flaky tail mice homozygous for filaggrin and mattrin mutations.
reduction in anti-PNE-specific IgE levels (Fig 8, C , group 1 compared with group 2 and Fig 8, C , group 5 compared with group 6) was less effective when there was skin pre-exposure to A alternata extract on PND3 to PND6 at the time of preexposure with oral PNE (Fig 8, C , group 1 compared with group 4 and Fig 8, C , group 5 compared with group 7).
DISCUSSION
We demonstrated that neonatal mice heterozygous for skin barrier mutations experience food allergy by means of skin sensitization with food allergens and coexposure to A alternata extract or HDM. Skin barrier mutations and A alternata extract or HDM were required to drive the development of food allergen sensitization, food-induced anaphylaxis, and inflammation and cytokines in the skin and intestine. Blocking ST2 during skin sensitization blocked anaphylaxis by FT 1/2 pups. The FT 1/2 neonates of allergic WT mothers had anaphylaxis and increased serum allergen-specific IgE levels to suboptimal skin challenges compared with FT 1/2 neonates of nonallergic WT mothers. Skin pre-exposure to the ubiquitous environmental allergen A alternata reduced oral PNE-induced tolerance in the presence of skin barrier mutations. These data demonstrate mechanisms for potent and rapid development of food allergies in offspring heterozygous for skin barrier mutations.
Animal studies of food allergy have included food exposure with bacterial toxins or prolonged antigen exposure. For instance, in small and large animals food allergy models include sensitization of adult mice through oral administration of food antigens with cholera toxin or intraperitoneal injection of food antigens with alum. 77 In studies with prolonged allergen exposure, OVA sensitization of adult mice is induced by a 49-day protocol with tape stripping and OVA skin patches held by semipermeable Tegaderm tape; this tape prevents passage of liquids and microbes while allowing moisture vapor and gas exchange. 78 Because mice are weaned at 21 days, the 49 days precludes the ability to analyze development of food allergy in neonates, the time when food allergy often develops in human subjects. In contrast, our studies demonstrate neonatal anaphylaxis with up to a 38C temperature decrease after rapid sensitization by 3 to 4 skin exposures to allergens. In another study adult WT mice were skin sensitized to OVA or peanut by using 2 weeks of daily tape stripping and concurrent application of the adjuvant calcipotriol (MC 903), but in these studies gavage with PNE decreased body temperature by only about 0.58C. 57 It has been reported that skin exposure to OVA in PBS exacerbates spontaneous skin inflammation in homozygous flaky tail mice but not in heterozygous FT 1/2 mice. 79 Consistent with this, in our studies with heterozygous FT 1/2 mice, PNE alone did not induce skin inflammation. However, we demonstrated that in heterozygous FT 1/2 neonatal mice A alternata drove robust food allergen-induced allergic inflammation and anaphylaxis. Thus exposure to food allergens along with components of house dust can potently sensitize patients with skin barrier mutations early in life.
Initiation of allergic responses at epithelial tissues in the skin or lungs of adult mice is regulated by production of innate cytokines, such as IL-33 and TSLP. 18, 80, 81 An increase in expression of CCL11 and IL-33 is also associated with human atopic dermatitis. 33 In our report sensitization by means of skin application of A alternata extract/PNE on FT 1/2 neonates increased skin TSLP, CCL11, and IL-33 levels and eosinophil counts and increased intestinal TSLP levels, demonstrating that there is induction of signals for initiation of allergic responses. In a 49-day skin sensitization protocol, blockade of the IL-33 receptor ST2 just before oral challenge significantly reduced the severity of oral anaphylaxis. 74 We demonstrate that ST2 blockade before each skin sensitization completely blocked oral antigen-induced anaphylaxis. Thus ST2 plays a key role in the development of anaphylaxis.
Food-specific IgE levels are low in children with food allergy and correlate poorly with food allergy. 4 IgG 1 can also mediate peanut antigen-induced anaphylaxis in the absence of IgE in animal models. 82 In adult mice IgE is necessary but not sufficient for oral food-induced anaphylaxis in a model with OVA sensitization in a protocol with 49 days of tape stripping and OVA skin patches. 78 In our studies with only 3 skin sensitizations with PNE/A alternata extract in neonatal FT 1/2 mice, there was anaphylaxis to oral antigen challenge despite very low anti-PNE IgE levels. This is consistent with reports in human subjects that food antigen-specific antibodies are not always associated with food responses and might be less than the detection limit in the serum. At low antigen-specific serum antibody concentrations with allergen responses, antibodies are likely to be found in tissues bound to Fc receptors on inflammatory cells. Our ongoing studies are determining functions of the antibodies and Fc receptors.
Allergic lung responses to low-dose allergen have been reported to be increased in offspring of allergic mothers, and responses in these offspring are not specific to the allergen to which the mother had been exposed. [6] [7] [8] [9] [10] [11] [12] 14, 15, 59, 60, 83 We demonstrated that the allergen to which the mother responds (OVA) can be different than the food allergen (PNE) of the offspring, and we demonstrate that offspring of allergic mothers respond to a protocol that is suboptimal for offspring of nonallergic mothers. Our ongoing studies are designed to determine maternal factors of allergic mothers that contribute to food allergy in FT 1/2 neonates.
Tolerance to food allergens has been studied in human subjects and mice. The clinical Learning Early about Allergy to Peanut studies suggest that early-life oral introduction of peanut at 4 to 11 months of age reduces the frequency of peanut allergy in children. 75, 76 Tolerance to food allergens has been studied in adult but not neonatal mice. Briefly, low-dose pre-exposure of allergic mother mice to peanut during pregnancy and lactation protects 5-week-old adult offspring from sensitization with oral peanut plus cholera toxin, but protection in the T H 2 environment of neonates was not studied. 84 Also, in mice aerosolized OVA exposure of nonallergic mothers during pregnancy protected 1-to 4-monthold adult offspring from intraperitoneal sensitization with OVA. 85 In contrast, in another report maternal exposure to peanut during mouse pregnancy and lactation did not protect development of anti-peanut antibodies in adult 5-week-old offspring that received peanut with alum adjuvant twice at 2-week intervals; however, when the 5-week-old adult offspring were fed peanut for 5 days before sensitization with peanut/alum, antibody generation was reduced. 86 In another study with adult mice, pre-exposure for 6 days with OVA in drinking water blocks development of atopic dermatitis induced in a 49-day sensitization protocol with OVAloaded skin patches that were held on the skin with semipermeable Tegaderm tape. 87 We demonstrated that tolerance can be induced in neonatal mice. In neonatal FT 1/2 mice anaphylaxis to food allergen was prevented by pre-exposure with oral PNE before skin sensitizations with PNE/Alt. Of potential concern for patients with skin barrier mutations, in the neonatal FT 1/2 mice, skin application with the ubiquitous allergen A alternata at the same time of pre-exposure with oral PNE reduced the induction of tolerance to PNE. Future studies will address mechanisms of A alternata inhibition of oral tolerance.
In human subjects peanut allergy in children is associated with exposure to peanut in household dust and exposure of peanut oils to inflamed skin in children, and household peanut consumption is associated with child peanut allergy. [88] [89] [90] House dust also contains A alternata and HDM. Thus in the environment of infants and children, there is often ubiquitous exposure to HDM, A alternata, and food allergens. Specifically, household dust contains peanut allergens at a level of 5 to 2200 mg of peanut/g of household dust, 45 Alt at 0.1 to 100 mg/g of household dust, 46, 47 and HDM antigens at about 12 mg of Der p 1 or Der p 2/g of dust. 43, 44 In our cause-and-effect studies, neonatal FT 1/2 mice received a 40-minute skin exposure of 10 mg of A alternata extract and 100 mg of PNE every 3 to 4 days, which is within the range for skin exposure in the household environment, and had anaphylaxis after oral challenge. At these doses, there was no synergy of A alternata with HDM (Fig 1) , suggesting that these doses found in house dust provide maximal sensitization through either A alternata or HDM in the presence of skin barrier mutations.
In infants and children loss-of-function mutations in skin barrier mutations associate with peanut allergy. 36, 89, 91, 92 Also, IgE-mediated food allergy is observed in up to 35% of children affected by atopic dermatitis. 29 Other reports predict that there are additional factors involved in development of food allergy. 91 Another factor might be soap components, such as sodium lauryl sulfate, which is sodium dodecyl sulfate (SDS), in cleansing wipes, which might facilitate allergen uptake during feeding and cleaning of infants with skin barrier mutations. We report that other factors, such as skin exposure of environmental allergens, along with application of SDS, can readily sensitize food allergen responsiveness in neonatal mice. In our studies SDS facilitated absorption of the topical application of the allergens, whereas without the SDS, the liquid droplet containing allergen remained as a droplet and the droplet rolled off of the skin.
To translate our findings to human subjects and their environment, for an infant that has skin barrier mutations, food allergen sensitization can occur very early in life through skin exposure to food allergens and concurrent skin exposure to soap in cleansing wipes and to HDMs, A alternata, and food allergens in house dust, bedding, blankets, and flooring and when handled by family members that are preparing or eating food. Moreover, these skin exposures occur early in infancy before clinical manifestations of atopic dermatitis. In children with FLG mutations, barrier defects precede clinical eczema diagnosis. 93 Interestingly, in our studies skin sensitization occurred in neonatal mice with skin barrier mutations well before the development of spontaneous atopic dermatitis skin lesions, which occur months later in FT 2/2 mice. 38 Furthermore, early pre-exposure to oral allergen before exposure to environmental allergy blocked development of anaphylaxis. This is consistent with a randomized, double-blind, placebo-controlled clinical trial that demonstrated that egg allergy is prevented by restoration of skin barrier function and early oral introduction of egg. 94 Future clinical food allergy studies in neonates and infants are needed to determine the effects of food allergen when stratifying subjects by loss of skin barrier function before development of atopic dermatitis. 93 In summary, these studies demonstrate mechanisms for development of food allergy driven by skin sensitization with environmental allergens in house dust and by skin barrier mutations. This is consistent with many features of early-life exposures and genetics in clinical food allergy. Moreover, offspring of allergic mothers had increased responses to a limited number of skin exposures, indicating that there is a maternal factor contributing to the development of food allergy. These studies of mechanisms for development of food allergen sensitization provide a basis toward designing studies to test interventions that more effectively modulate these pathways in allergic disease. Currently, avoidance of triggering food allergens is a main treatment with a profound negative effect on quality of life. 95 More studies are needed in human subjects to examine mechanisms for development of food allergy and mechanisms for induction of tolerance to food allergens early in life.
We thank Derek Carter for preparing and staining the skin tissue sections.
Key messages
d In neonatal mice concurrent skin exposure with food and environmental allergens leads to induction of food allergy before clinical manifestations of atopic dermatitis.
d Neonatal pups with heterozygous skin barrier mutations from WT allergic mothers have increased food allergen sensitization, inflammatory mediators, and anaphylaxis to food allergen challenge compared with offspring of nonallergic mothers or offspring without skin barrier mutations.
d Blockade of ST2 during skin sensitization inhibited anaphylaxis and inflammatory mediators.
d In neonates tolerance to food allergens is blunted by concurrent pre-exposure of the skin to environmental allergen during oral pre-exposure to food allergen.
METHODS Tissue analysis of inflammatory mediators
At the indicated day in the figures, pups were weighed and killed, and tissues were collected. Peripheral blood was collected in heparin tubes, and blood eosinophils were counted in a 1:10 dilution in Discomb stain (1 part acetone, 1 part 2% aqueous eosin, and 8 parts distilled water).
E1,E2 Eosinpositive eosinophils were counted with a hemacytometer (catalog no. 0267110; Thermo Fisher Scientific).
E3
Serum was collected for analysis of antigen-specific antibodies. Skin punches and intestines were collected for histology or quantitative PCR of mediators of inflammation. Neonate intestines were flushed with saline and fixed with 4% formaldehyde in PBS overnight, followed by 30 minutes in 30% sucrose in PBS. The intestines were frozen in OCT and stored at 2808C. Intestinal tissue sections were stained with 0.1% toluidine blue (0.1% toluidine blue in 7% ethanol and 1% NaCl, pH 2.3) for mast cells or with eosin and a light methyl-green counterstain (EMG stain) for eosinophils. E3 Paraffin-embedded skin tissue sections were processed for histology with toluidine blue for mast cells or with an eosin and light hematoxylin counterstain for eosinophils. 
Genotyping for
SDS-PAGE analysis of allergens
PNE was incubated at room temperature with or without A alternata extract for 40 minutes in the same protein ratio as applied to the neonatal mice. SDS-PAGE was performed with 10% acrylamide gels. The gels were stained with SimplyBlue SafeStain (catalog no. LC6060; Thermo Fisher) and imaged with an Odyssey CLx (LI-COR, Lincoln, Neb).
FIG E1. FT
1/2 Pups were treated with 3 skin applications of A alternata extract/PNE as in Fig 1. A and B, Representative images of pup skin after gentle paper taping on PND3 and PND6 to gently remove dry, shedding skin after birth. C, Representative image of pup skin on PND9 after shaving and then taping with paper tape to remove loose shaved fur.
FIG E2.
OVA/A alternata extract or OVA/HDM skin sensitization of FT 1/2 neonate-induced responsiveness to anaphylaxis. A, Timeline for mating and for FT 1/2 pup treatments. B, Food allergen-induced temperature (in degrees Celsius) changes on day 21. C, Anti-OVA-specific serum IgE (n 5 8-10 per group). *P < .05 compared with the saline skin-sensitized groups. Alt, Alternaria alternata extract; FT1/2, flaky tail mice heterozygous for filaggrin and for mattrin mutations; FT2/2, flaky tail mice homozygous for filaggrin and mattrin mutations.
FIG E3.
There were no differences in response by sex and no differences in pup body temperature by sex before oral challenge. A, These are the same data as from Fig 1 but separated here by sex. *P < .05 compared with the saline skin-sensitized groups. B, For pups from Fig 1, there was no difference in initial body temperature by sex or treatment just before oral challenge on PND21. Alt, Alternaria alternata extract; F, female; FT1/2, flaky tail mice heterozygous for filaggrin and for mattrin mutations; FT2/2, flaky tail mice homozygous for filaggrin and mattrin mutations; M, male.
FIG E4.
There was no indication of any new major band sizes after coincubation of A alternata extract (Alt) with PNE or coincubation of HDM with PNE. Coincubation of PNE with A alternata extract (A) or HDM (B) at room temperature for 20 or 45 minutes, followed by SDS-PAGE and staining with SimplyBlue is shown. Indicated are sizes for the major peanut proteins (Ara h 1, Ara h 3 acidic subunits, Ara h 3 basic subunit, Ara h 2, and Ara h 6). MW, Molecular weight.
FIG E5.
Endotoxin amounts in fecal pellets in the mouse cage and in allergens for each skin treatment. Endotoxin was measured by using the LAL chromogenic assay. Presented are endotoxin levels for each fecal pellet in cage bedding, 100 mg of PNE, 10 mg of A alternata extract (Alt), 10 mg of HDM, and 100 mg of OVA because these are the amounts applied to the skin at each treatment. *P < .05 compared with other groups.
FIG E6.
OVA-allergic female mothers had OVA-specific serum IgE levels measured. These are allergic and saline-treated mothers that were treated as in Fig 2. Serum was collected on gestational day 18, and OVA-specific IgE levels were measured by means of ELISA. *P < .05.
FIG E7.
Initial body temperature measured immediately before oral challenge increased with age but did not differ between pups of saline-treated and allergic mothers. Shown are initial body temperatures measured immediately before oral challenge for pups in Fig 3. *P < .05 compared with the corresponding group with 1 fewer skin sensitization. Alt, A alternata extract. Oral preexposure to PNE to induce tolerance in FT 1/2 pups was less effective (Fig 8, group 4) when skin was pre-exposed to the ubiquitous environmental allergen A alternata during oral pre-exposure to PNE compared with induction of tolerance with oral PNE in the absence of A alternata before exposure (Fig 7, group 4 ). *P < .05 compared with the group without the asterisk. Alt, Alternaria alternata extract; FT1/2, flaky tail mice heterozygous for filaggrin and for mattrin mutations; FT2/2, flaky tail mice homozygous for filaggrin and mattrin mutations.
